Vigil Neuroscience, Inc.
DelistedCIK 1827087fmd_1ACDESX60XS00ER08Q1YGW5C1MManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2021 to Jun 30, 2025, 18 periods
Latest annual · FY2024
Millions- Operating income
- (90)
- Net income
- (84)
- Free cash flow
- (51)
Latest quarter · Q2 FY2025
Millions- Operating income
- (27)
- Net income
- (27)
- Free cash flow
- (21)
Vigil Neuroscience, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$89.7 million | -$88.9 million | 10-K 2025-03-13 · proof | |
| Net income | -$84.3 million | -$82.6 million | 10-K 2025-03-13 · proof | |
| Cash from operating activities | -$51.2 million | -$70.4 million | 10-K 2025-03-13 · proof | |
| Free cash flow | -$51.2 million | -$71 million | 10-K 2025-03-13 · proof | |
| Total assets | $117.7 million | $140.9 million | -16.4% | 10-K 2025-03-13 · proof |
| Total liabilities | $46.1 million | $24.6 million | +87.2% | 10-K 2025-03-13 · proof |
| Cash and cash equivalents | $39 million | $52 million | -25% | 10-K 2025-03-13 · proof |
- What was Vigil Neuroscience, Inc.'s operating income in fiscal 2024?
- Vigil Neuroscience, Inc. reported operating income of -$89.7 million for fiscal 2024 (the year ended Dec 31, 2024), against -$88.9 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Vigil Neuroscience, Inc.'s net income in fiscal 2024?
- Vigil Neuroscience, Inc. reported net income of -$84.3 million for fiscal 2024 (the year ended Dec 31, 2024), against -$82.6 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Vigil Neuroscience, Inc.'s cash from operating activities in fiscal 2024?
- Vigil Neuroscience, Inc. reported cash from operating activities of -$51.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$70.4 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What was Vigil Neuroscience, Inc.'s free cash flow in fiscal 2024?
- Vigil Neuroscience, Inc. reported free cash flow of -$51.2 million for fiscal 2024 (the year ended Dec 31, 2024), against -$71 million the year before. Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Vigil Neuroscience, Inc.'s total assets?
- As of Dec 31, 2024, Vigil Neuroscience, Inc. reported total assets of $117.7 million, against $140.9 million a year earlier (-16.4%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Vigil Neuroscience, Inc.'s total liabilities?
- As of Dec 31, 2024, Vigil Neuroscience, Inc. reported total liabilities of $46.1 million, against $24.6 million a year earlier (+87.2%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
- What are Vigil Neuroscience, Inc.'s cash and cash equivalents?
- As of Dec 31, 2024, Vigil Neuroscience, Inc. reported cash and cash equivalents of $39 million, against $52 million a year earlier (-25%). Source: the 10-K filed with the SEC on Mar 13, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1827087&period_type=annual&limit=5"Information only, not investment advice.